Product and Pipeline Assessment of the Global Orphan Drugs Market

Attractive Market Lures Hundreds of Innovators, Large and Small
Share this:
     
Published: 27 Feb 2014

Breakthroughs in drug discovery have led to rich and competitive pipelines for rare diseases such as rare cancers as well as neurologic disorders and musculoskeletal disorders, among many other therapeutic areas. This research service provides a comprehensive global overview and analysis of global orphan drugs development, with an emphasis on the US market. Included are market background and global overview and analysis of drug development and regulatory activity by disease area and geography, detailed product and pipeline analysis of orphan drugs by therapeutic area and disease, and company analysis, including activity analysis and key companies to watch.

  1.  
  2.  
  3.  
  4.  
  5.  
  6.  
  7.  
  8.  
  9.  
  10.  
  11.  
  12.  
  13.  
  14.  
  15.  
  16.  
  17.  
  18.  
  19.  
  20.  
  21.  
  22.  
  23.  

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..